| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |